MedPath

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

Not Applicable
Active, not recruiting
Conditions
Schizophrenia
Interventions
Other: Placebo
Other: Auditory Stimulation
Registration Number
NCT04783571
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance under two conditions separated by one week: receiving auditory stimulation during sleep and not receiving auditory stimulation during sleep. The investigators will study healthy subjects and outpatients with schizophrenia.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria

For healthy controls:

  • Male and female subjects
  • 18-50 years of age
  • Proficient in English

For schizophrenia patients:

  • Male and female schizophrenia outpatients
  • 18-50 years of age
  • Proficient in English
  • Able to give informed consent
Exclusion Criteria
  • Pregnant females
  • Current use of psychotropic medications (healthy controls only)
  • A history of head injury resulting in prolonged loss of consciousness or other neurological sequelae
  • IQ <85
  • Neurological disorder (including seizure disorder)
  • Significant hearing or vision loss
  • Current substance abuse or dependence (nicotine abuse or dependence is not exclusionary)
  • Any unstable chronic medical condition that affects sleep
  • Diagnosed sleep disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Healthy ControlsPlaceboAdult participants screened to exclude a personal history of mental illness, family history of schizophrenia spectrum disorder, and psychoactive medication use.
SchizophreniaAuditory StimulationAdult outpatients with a diagnosis of schizophrenia.
SchizophreniaPlaceboAdult outpatients with a diagnosis of schizophrenia.
Healthy ControlsAuditory StimulationAdult participants screened to exclude a personal history of mental illness, family history of schizophrenia spectrum disorder, and psychoactive medication use.
Primary Outcome Measures
NameTimeMethod
Differences in slow-oscillation spindle couplingPlacebo and auditory stimulation naps will be approximately one week apart

Differences in slow oscillation-spindle coupling during non-rapid eye movement (NREM) sleep as measured by EEG between placebo and auditory stimulation naps

Secondary Outcome Measures
NameTimeMethod
Differences in slow oscillationsPlacebo and auditory stimulation naps will be approximately one week apart

Differences in slow oscillations during non-rapid eye movement (NREM) sleep as measured by EEG between placebo and auditory stimulation naps

Differences in sleep spindlesPlacebo and auditory stimulation naps will be approximately one week apart

Differences in sleep spindles during non-rapid eye movement (NREM) sleep as measured by EEG between placebo and auditory stimulation naps

Differences in sleep-dependent consolidation of motor procedural memoryPlacebo and auditory stimulation naps will be approximately one week apart

Differences in sleep-dependent improvement of motor procedural memory performance on the finger tapping motor sequence task (MST) between placebo and auditory stimulation naps. The MST involves pressing four numerically labeled keys on a standard keypad, repeating a 5 digit sequence as quickly and accurately as possible for 12 trials at 30 seconds each separated by 30 sec rest periods. Different sequences are employed for the placebo and stimulation visits in a counter-balanced order.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath